- Home
- JNVR vs BGLC Comparison
JNVR vs BGLC Comparison
Compare JNVR & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- BGLC
- Stock Information
- Founded
- JNVR 2018
- BGLC 2017
- Country
- JNVR United States
- BGLC Malaysia
- Employees
- JNVR N/A
- BGLC N/A
- Industry
- JNVR Finance: Consumer Services
- BGLC Medical Specialities
- Sector
- JNVR Finance
- BGLC Health Care
- Exchange
- JNVR Nasdaq
- BGLC Nasdaq
- Market Cap
- JNVR 7.0M
- BGLC 5.8M
- IPO Year
- JNVR 2023
- BGLC N/A
- Fundamental
- Price
- JNVR $4.72
- BGLC $0.35
- Analyst Decision
- JNVR
- BGLC
- Analyst Count
- JNVR 0
- BGLC 0
- Target Price
- JNVR N/A
- BGLC N/A
- AVG Volume (30 Days)
- JNVR 7.2K
- BGLC 179.2K
- Earning Date
- JNVR 03-27-2025
- BGLC 03-04-2025
- Dividend Yield
- JNVR N/A
- BGLC N/A
- EPS Growth
- JNVR N/A
- BGLC N/A
- EPS
- JNVR N/A
- BGLC N/A
- Revenue
- JNVR $1,820,969.00
- BGLC $9,259,858.00
- Revenue This Year
- JNVR N/A
- BGLC N/A
- Revenue Next Year
- JNVR N/A
- BGLC N/A
- P/E Ratio
- JNVR N/A
- BGLC N/A
- Revenue Growth
- JNVR N/A
- BGLC N/A
- 52 Week Low
- JNVR $3.37
- BGLC $0.21
- 52 Week High
- JNVR $11.84
- BGLC $1.20
- Technical
- Relative Strength Index (RSI)
- JNVR 40.24
- BGLC 46.44
- Support Level
- JNVR $4.91
- BGLC $0.33
- Resistance Level
- JNVR $5.35
- BGLC $0.40
- Average True Range (ATR)
- JNVR 0.25
- BGLC 0.02
- MACD
- JNVR -0.08
- BGLC -0.01
- Stochastic Oscillator
- JNVR 15.30
- BGLC 23.07
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.